Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adulterated, Agriculture, Annex, attorney, backbone, BeyondSpring, biochemical, blinded, border, Britain, CJEU, closure, codified, Colorado, combat, compel, conflict, content, Council, crime, CRL, cultural, cut, cyber, cybersecurity, decree, deletion, delta, deployment, description, developmental, diarrhea, disability, docetaxel, doxorubicin, drew, Eastern, embedded, engineering, England, equitable, evidentiary, fall, Florida, fluid, forgiven, foster, fostering, freestanding, furlough, gouging, Great, Hampshire, HMR, ID, IDE, inevitable, Inline, inspired, invasion, invitro, Ireland, IVDD, legitimize, malware, match, matching, MDR, MHRA, mission, month, neoadjuvant, omicron, opine, pace, Page, partnership, payer, phishing, PREA, preexisting, prerequisite, presidential, qualitative, quantitative, ransomware, recurrent, refinement, registry, Russia, Russian, salvaged, save, Scotland, Senate, shut, shutdown, SI, SIP, sophisticated, sophistication, Summer, terrorist, theft, tie, transient, transmit, transmitted, Ukraine, unblinded, uncommon, unexpired, Unitary, UPC, upregulation, Vermont, Welfare, wholesale, wholly, workplace
Removed:
abandoned, accidental, accumulation, activating, adapt, affinity, allocation, assigning, assumed, assumption, attempt, authorisation, bioactive, biophysical, Byetta, ceased, classifying, Codification, computing, concept, concluding, configuration, confirm, confirmatory, conjunction, consummated, consummation, contractually, coordination, credibility, Declaration, deductibility, defective, diligent, displace, dominant, easily, electorate, emerged, employer, enhancement, entitling, erected, evolutionarily, exenatide, falsification, finalizing, forego, Forteo, FoundationOne, fraudulently, functionality, halted, helical, Ibrance, idasanutlin, illustrated, image, IMM, imputed, inhibiting, inhibition, inside, insulin, interacting, intervention, intracellular, investigating, knee, leakage, left, legally, lessee, Linaclotide, linker, liraglutide, marker, mice, modality, modernize, modulate, mouse, mutation, native, ninety, nonqualified, optimization, Parliament, path, penetrance, penetrate, physiochemical, pipeline, plasma, poor, potency, proof, protease, proven, PTCL, pursuit, quantity, radiographic, Radiological, rational, redeemable, remeasured, rendered, repair, resistance, responding, reveal, rolled, routine, rulemaking, scaffold, Schema, scientifically, senolytic, shallower, shape, solution, speed, spur, stabilization, step, sum, surface, surgery, template, teriparatide, thought, today, translated, typical, unaudited, underlying, understand, unvested, unwinding, updated, verify, Victoza, voted, war, xenograft, yielded
Filing tables
Filing exhibits
ALRN similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Aileron Therapeutics, Inc. (the “Company”) for the period ending December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: March 28, 2022 |
| /s/ Manuel C. Alves Aivado, M.D., Ph.D. |
|
| Manuel C. Alves Aivado, M.D., Ph.D. |
|
| President and Chief Executive Officer |